New Research Highlights Muscle Loss Risks from GLP-1 Drugs in the USA
Read Time:39 Second
Recent research has brought attention to the risks of muscle loss associated with GLP-1 drugs like Ozempic and Zepbound, widely used in the USA for weight loss.
Key Findings
- GLP-1 medications effectively reduce fat quickly.
- However, they may also cause significant muscle loss.
- Muscle loss can negatively impact strength and overall health.
Expert Recommendations
To mitigate these risks, medical professionals recommend:
- Combining GLP-1 drug treatments with exercise.
- Ensuring proper nutrition to preserve muscle mass.
- Engaging in ongoing studies to develop optimal care strategies.
Maintaining muscle is crucial for both daily activities and long-term wellness. This research highlights the importance of balancing effective weight loss with preserving muscle health for the millions of Americans using these drugs.
Stay tuned for further updates from Questiqa USA on this evolving topic.

Average Rating